Shilin Chen, PhD

CTO, CO-FOUNDER

Shilin is a recent PhD graduate at the Department of Chemical and Biomolecular Engineering (CBE) at University of California, Los Angeles (UCLA). His research focuses on nanomaterials-based delivery system for cancer therapeutics, particularly in using polymers with acetylcholine analogues to encapsulate monoclonal antibodies to facilitate their transport across the blood brain barrier. Additionally, he is also experienced in microfluidic platform development for cancer spheroid culturing and drug screening from his research. During his PhD program, he also served as the vice president of the Chemical Engineering Graduate Student Council, a student-run organisation providing academic and wellness support for the graduate student body at CBE.

Originally hailed from Chengdu, China, he conducted his undergraduate and master studies at University of California, Berkeley (UC Berkeley) before relocating to Los Angeles for his PhD programme.

In his spare time, he continues to make music with his college rock band The Boba Guys and practice taewondo with 1st degree blackbelt. His interests in nanomaterials, microfluidics, cancer therapeutics and chemical engine background led him to the position as the Chief Technology Officer of GambitBio.